Home
>
National Drug Code (NDC)
>
Curosurf
Curosurf - 10122-510-03 - (poractant alfa)
Drug Information of Curosurf
| Product NDC: | 10122-510 |
| Proprietary Name: | Curosurf |
| Non Proprietary Name: | poractant alfa |
| Active Ingredient(s): | 80 mg/mL & nbsp; poractant alfa |
| Administration Route(s): | ENDOTRACHEAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Curosurf
| Product NDC: | 10122-510 |
| Labeler Name: | Cornerstone Therapeutics Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020744 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19991118 |
Package Information of Curosurf
| Package NDC: | 10122-510-03 |
| Package Description: | 3 mL in 1 VIAL, GLASS (10122-510-03) |
NDC Information of Curosurf
| NDC Code | 10122-510-03 |
| Proprietary Name | Curosurf |
| Package Description | 3 mL in 1 VIAL, GLASS (10122-510-03) |
| Product NDC | 10122-510 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | poractant alfa |
| Dosage Form Name | SUSPENSION |
| Route Name | ENDOTRACHEAL |
| Start Marketing Date | 19991118 |
| Marketing Category Name | NDA |
| Labeler Name | Cornerstone Therapeutics Inc. |
| Substance Name | PORACTANT ALFA |
| Strength Number | 80 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Alveolar Surface Tension Reduction [PE],Surfactant [EPC],Surfactant Activity [MoA] |
